You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Screening for bile acid diarrhoea in suspected irritable bowel syndrome
  1. Imran Aziz1,
  2. Matthew Kurien1,
  3. David S Sanders1,
  4. Alexander C Ford2,3
  1. 1 Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK
  2. 2 Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK
  3. 3 Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK
  1. Correspondence to Dr Alexander C Ford, Leeds Gastroenterology Institute, Room 125, 4th Floor, Bexley Wing, St. James's University Hospital, Beckett Street, Leeds LS9 7TF, UK; alexf12399{at}yahoo.com

https://doi.org/10.1136/gutjnl-2014-307579

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read the paper by Bajor et al with interest.1 The authors demonstrated that 18% of patients who meet criteria for IBS may have underlying bile acid diarrhoea (BAD), using 23-seleno-25-homo-tauro-cholic acid (SeHCAT) scanning. This issue has been the subject of a previous systematic review and meta-analysis2 which reported that up to 30% of individuals with IBS had evidence of idiopathic BAD. However, many of the included studies were retrospective, and few used accepted symptom-based criteria to define the presence of IBS, underlining the importance of the data from Bajor et al 1 who recruited a well characterised and rigorously defined cohort of patients meeting the Rome II criteria for IBS.

    We therefore congratulate the authors …

    View Full Text

    Footnotes

    • Contributors All authors wrote and contributed equally in this manuscript.

    • Competing interests DSS and ACF have received grant support and speakers’ fees from GE Healthcare.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles